Relapsed Non Hodgkin Lymphoma Not Yet Recruiting Phase 1 Trials for Fludarabine (DB01073)

IndicationStatusPhase
DBCOND0062858 (Relapsed Non Hodgkin Lymphoma)Not Yet Recruiting1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03774654CD19.CAR Allogeneic NKT for Patients With Relapsed or Refractory B-Cell Malignancies (ANCHOR)Treatment